Arena Pharmaceuticals, Inc. (ARNA) Reports In-Line Q4 Loss; Guides FY14
Tweet Send to a Friend
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) reported Q4 EPS of ($0.11), in-line with the analyst estimate of ($0.11). Revenue for the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
